Literature DB >> 18309244

Artificial neural network model is superior to logistic regression model in predicting treatment outcomes of interferon-based combination therapy in patients with chronic hepatitis C.

Chun-Hsiang Wang1, Lein-Ray Mo, Ruey-Chang Lin, Jen-Juan Kuo, Kuo-Kuan Chang, Jieh-Jen Wu.   

Abstract

BACKGROUND/AIMS: Patients with chronic hepatitis C (CHC) can achieve a sustained virologic response if they received pegylated interferon plus ribavirin therapy; however, some of them do not respond or relapse after treatment. The aim of this study was to compare the ability of two statistical models to predict treatment outcomes.
METHODS: Clinical data, biochemical values, and liver histological features of 107 patients with CHC were collected and assessed using a logistic regression (LR) model and an artificial neural network (ANN) model. Both the LR and ANN models were compared by receiver-operating characteristics curves.
RESULTS: Aspartate aminotransferase (p = 0.017), prothrombin time (p = 0.002), body mass index (BMI; p = 0.003), and fibrosis score of liver histology (p = 0.002) were found to be significant predictive factors by univariate analysis. The independent significant predicting factor was BMI by multivariate LR analysis (p = 0.0095). The area under receiver-operating characteristics of the ANN model was larger than that of the LR model (85 vs. 58.4%).
CONCLUSIONS: It was found that BMI is an independent factor for identifying patients with favorable treatment response. A useful ANN model in predicting outcomes of standard treatment for CHC infection was developed and showed greater accuracy than the LR model. Copyright (c) 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18309244     DOI: 10.1159/000118791

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  7 in total

1.  Impact of FokI (rs10735810) and BsmI (rs1544410) on Treatment of Chronic HCV Patients With Genotype 4.

Authors:  Olfat Shaker; Yasser Nassar; Shymaa Ayoub; Maissa Elrazki; Amr Zahra
Journal:  J Clin Lab Anal       Date:  2016-04-18       Impact factor: 2.352

2.  A noninvasive artificial neural network model to predict IgA nephropathy risk in Chinese population.

Authors:  Jie Hou; Shaojie Fu; Xueyao Wang; Juan Liu; Zhonggao Xu
Journal:  Sci Rep       Date:  2022-05-18       Impact factor: 4.996

3.  Identification of the risk for liver fibrosis on CHB patients using an artificial neural network based on routine and serum markers.

Authors:  Danan Wang; Qinghui Wang; Fengping Shan; Beixing Liu; Changlong Lu
Journal:  BMC Infect Dis       Date:  2010-08-24       Impact factor: 3.090

4.  Mortality predicted accuracy for hepatocellular carcinoma patients with hepatic resection using artificial neural network.

Authors:  Herng-Chia Chiu; Te-Wei Ho; King-Teh Lee; Hong-Yaw Chen; Wen-Hsien Ho
Journal:  ScientificWorldJournal       Date:  2013-04-30

Review 5.  Complementarity of Clinician Judgment and Evidence Based Models in Medical Decision Making: Antecedents, Prospects, and Challenges.

Authors:  Zhou Lulin; Ethel Yiranbon; Henry Asante Antwi
Journal:  Biomed Res Int       Date:  2016-08-24       Impact factor: 3.411

6.  Forecasting the seasonality and trend of pulmonary tuberculosis in Jiangsu Province of China using advanced statistical time-series analyses.

Authors:  Qiao Liu; Zhongqi Li; Ye Ji; Leonardo Martinez; Ui Haq Zia; Arshad Javaid; Wei Lu; Jianming Wang
Journal:  Infect Drug Resist       Date:  2019-07-26       Impact factor: 4.003

7.  Predicting the outcomes of combination therapy in patients with chronic hepatitis C using artificial neural network.

Authors:  Forough Sargolzaee Aval; Nazanin Behnaz; Mohamad Reza Raoufy; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2014-06-01       Impact factor: 0.660

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.